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With treatment to remission as the gold standard for
depression treatment, there is considerable reassessment
of treatment approaches with the view to finding and
employing agents capable of rapidly eliminating all symp-
toms and returning patients to normalcy. The selective
serotonin reuptake inhibitors (SSRIs), the most com-
monly prescribed antidepressants, have a single-action
mechanism involved in modulating the reuptake of the
neurotransmitter serotonin. The selectivity of the SSRIs
renders them safer and more tolerable than the earlier
multi-acting monoamine oxidase inhibitors (MAOIs) and
the tricyclic antidepressants (TCAs). However, because
serotonin is not the only neurotransmitter implicated in
the pathophysiology of depression, the selectivity that
bestows safety to SSRIs may limit somewhat the antide-
pressant effect in some patients. A newer class of dual-
action antidepressants is characterised by inhibiting both
serotonin and noradrenaline at the presynaptic mem-
brane and by a weak affinity with receptors at the postsy-
naptic membrane. These serotonin-norepinephrine
reuptake inhibitors (SNRIs) have improved side effect
profiles compared with the earlier multi-action antide-
pressants, compare favorably with the SSRIs on safety and
tolerability, and reduce depression and its associated
symptoms with greater rapidity. In addition, there is evi-
dence that they may have prophylactic properties in pre-
venting major depressive episodes.
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